PIPERACILLIN SODIUM and TAZOBACTAM SODIUM
- Product NDC
- 70594-080
- 11-digit product format
- 705940080
- Labeler code
- 70594
- Product ID
- 70594-080_7b8413a0-a8bd-4899-8567-677034eb0a7d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PIPERACILLIN SODIUM and TAZOBACTAM SODIUM
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Xellia Pharmaceuticals USA LLC
- Application
- ANDA212287
- Marketing category
- ANDA
- Marketing start
- 2021-01-10
- Marketing end
- 0000-00-00
- Substance
- PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- Active strength
- 4 g/150mL; mg/150mL
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70594-080 | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM INJECTION, POWDER, FOR SOLUTION [XELLIA PHARMACEUTICALS USA LLC] | 4 | Legacy NDC | 20241212_184b5961-1ae7-474c-afaa-2a2b2ccfc9cd.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70594-080-02 | 70594008002 | 10 VIAL in 1 CARTON (70594-080-02) > 150 mL in 1 VIAL (70594-080-01) | 10 vial | 2021-01-10 | 0000-00-00 | No | No | Current |